VBIO CIK: 1787740

Valion Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
14.3
FY22:
5.31
FY23:
4.65
FY24:
2.64
FY25:
13.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.75
FY22:
0.57
FY23:
0.51
FY24:
0.17
FY25:
18.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
15.0
FY22:
5.88
FY23:
5.16
FY24:
2.81
FY25:
31.6

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
1.22
FY22:
1.88
FY23:
1.40
FY24:
0.27
FY25:
0.65
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.55
FY22:
0.37
FY23:
0.18
FY24:
0
FY25:
6.79
(positive)
Change from FY21 to FY25
millions USD
FY21:
13.3
FY22:
3.63
FY23:
3.58
FY24:
2.54
FY25:
16.8
Total liabilities & equity
Change from FY21 to FY24
millions USD
FY21:
15.0
FY22:
5.88
FY23:
5.16
FY24:
2.81
FY25:
–

All amounts in millions USD Data source:SEC EDGAR